Senior Researcher in Pharmacoepidemiology
University of Oxford, United Kingdom
Eng Hooi (Cheryl) Tan, PhD is a senior researcher in pharmacoepidemiology at the University of Oxford. She has experience working with multinational cohort studies using real world data in various therapeutic areas including cancer, osteoporosis, and autoimmune diseases. She has led and contributed to studies in European initiatives such as DARWIN-EU and OPTIMA consortium. Her research interests are in comparative effectiveness/safety methods and causal inference.